Logotype for Ambiq Micro Inc

Ambiq Micro (AMBQ) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Ambiq Micro Inc

Q3 2025 earnings summary

15 Nov, 2025

Executive summary

  • Q3 2025 net sales reached $18.2 million, surpassing guidance but down 10.4% year-over-year, with one of the strongest gross margins to date and a strengthened balance sheet post-IPO.

  • Strategic pivot to high-value, AI-driven markets accelerated growth, with robust design funnel, increased orders from new and existing customers, and strong Apollo 5 adoption.

  • Expanded product portfolio with launches of Apollo510 Lite SoC Series and Helio AI Runtime, supporting edge AI growth in wearables, industrial, and AR glasses.

  • Completed IPO in July 2025, raising $102.7 million and converting all preferred stock to common stock, significantly strengthening cash position.

  • SPOT platform recognized by Time Magazine as one of the best AI inventions of 2025.

Financial highlights

  • Q3 2025 net sales were $18.2 million, down 10.4% year-over-year but up 1.6% sequentially; gross margin improved to 44.8% (non-GAAP) and 42.3% (GAAP), up over 10 points year-over-year.

  • Non-GAAP gross profit was $8.1 million, up 16.8% year-over-year; GAAP gross profit was $7.7 million, up 16.4%.

  • Non-GAAP net loss attributable to common stockholders was $4 million, improving $1.9 million sequentially and $1.8 million year-over-year; GAAP net loss was $9.0 million.

  • Ended Q3 with no debt and $146.5 million in cash and equivalents, reflecting IPO proceeds.

  • Operating expenses (GAAP) were $17.7 million, up from $16.7 million year-over-year; non-GAAP operating expenses were $13.2 million, nearly flat year-over-year.

Outlook and guidance

  • Q4 2025 net sales expected between $18.5 and $19.5 million, above consensus estimate of $14.2 million and the highest quarterly revenue of 2025.

  • Non-GAAP loss per share for Q4 expected between $0.44 and $0.34, based on 18.2 million pro forma shares.

  • Guidance includes higher variable expenses and a $1–1.5 million non-cash OpEx increase due to IP cost reclassification.

  • Management anticipates continued revenue growth and gross margin expansion in 2026 and 2027, with Atomic platform revenues expected to contribute meaningfully in 2028.

  • Cash on hand and anticipated cash from operations are expected to be sufficient for at least the next twelve months.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more